Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Claudia A M Stege, A"'
Autor:
Kazimierz Groen, Febe Smits, Kazem Nasserinejad, Mark‐David Levin, Josien C. Regelink, Gert‐Jan Timmers, Esther G. M. deWaal, Matthijs Westerman, Gerjo A. Velders, Koen deHeer, Rineke B. L. Leys, Roel J. W. vanKampen, Claudia A. M. Stege, Maarten R. Seefat, Inger S. Nijhof, Ellen van derSpek, Saskia K. Klein, Niels W. C. J. van deDonk, Paula F. Ypma, Sonja Zweegman
Publikováno v:
HemaSphere, Vol 8, Iss 7, Pp n/a-n/a (2024)
Externí odkaz:
https://doaj.org/article/35ff82dc826f4e589fe20f0d84490eb9
Autor:
M. Christine Bennink, Claudia A. M. Stege, Birgit I. Lissenberg-Witte, Simone Oerlemans, Maarten R. Seefat, Pieter Sonneveld, Sonja Zweegman
Publikováno v:
HemaSphere, Vol 6, Iss 7, p e744 (2022)
Externí odkaz:
https://doaj.org/article/890e89fa16f446c198648bfca6dc46dd
Autor:
Tim Schutte, Claudia A. M. Stege, Mark M. Smits, Laurens E. Franssen, Marjolein L. Donker, David C. de Leeuw
Publikováno v:
Clinical drug investigation. Adis International Ltd
Schutte, T, Stege, C A M, Smits, M M, Franssen, L E, Donker, M L & de Leeuw, D C 2022, ' Midostaurin as the Most Likely Cause of Bilateral Adrenal Masses in a Patient with Acute Myeloid Leukemia ', Clinical drug investigation . https://doi.org/10.1007/s40261-022-01186-y
Schutte, T, Stege, C A M, Smits, M M, Franssen, L E, Donker, M L & de Leeuw, D C 2022, ' Midostaurin as the Most Likely Cause of Bilateral Adrenal Masses in a Patient with Acute Myeloid Leukemia ', Clinical drug investigation . https://doi.org/10.1007/s40261-022-01186-y
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e29cc72c2737f2210ccb8ed8fbbe93b8
https://doi.org/10.1007/s40261-022-01186-y
https://doi.org/10.1007/s40261-022-01186-y
Autor:
Sonja Zweegman, Zweegman, Claudia A M Stege, A, Haukås, Einar, Schjesvold, Fredrik H, Mark-David Levin, Levin, Waage, Anders, Rineke B L Leys, B, Saskia K Klein, K, Szatkowski, Damian Lukasz, Per Axelsson, Axelsson, Trung Hieu Do, Hieu, Dorota Knut-Bojanowska, Knut-Bojanowska, Ellen van der Spek, van, Asta Svirskaite, Svirskaite, Anja Klostergaard, Klostergaard, Morten Salomo, Salomo, Celine Blimark, Blimark, Paula F Ypma, F, Ulf-Henrik Mellqvist, Mellqvist, Pino J Poddighe, J, Marian Stevens-Kroef, Stevens-Kroef, Niels W C J van de Donk, W, Pieter Sonneveld, Sonneveld, Markus Hansson, Hansson, Bronno van der Holt, van, Niels Abildgaard, Abildgaard
Externí odkaz:
https://hdl.handle.net/11250/2733197
Autor:
Claudia A M, Stege, Bronno, van der Holt, Avinash G, Dinmohamed, Pieter, Sonneveld, Mark-David, Levin, Niels W C J, van de Donk, Ulf-Henrik, Mellqvist, Anders, Waage, Sonja, Zweegman
Publikováno v:
Leukemia
Patients with multiple myeloma are generally older and vary in fitness levels, which may influence the clinical benefit of treatment. Patients from the large, phase 3 FIRST trial in newly diagnosed multiple myeloma (NDMM) were retrospectively investi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::30539770be779379f4804e6fa62e9e28
https://pubmed.ncbi.nlm.nih.gov/31427722
https://pubmed.ncbi.nlm.nih.gov/31427722